Sort   by:  
 Page size 
UnknownArsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Not available
S-EPMC6010577 | biostudies-literature
UnknownStromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia.
Not available
S-EPMC6769009 | biostudies-literature
UnknownA phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide.
Not available
S-EPMC7163093 | biostudies-literature
UnknownManagement of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimens.
Not available
S-EPMC7894296 | biostudies-literature
UnknownRationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
Not available
S-EPMC5097069 | biostudies-literature
UnknownPlasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients.
Not available
S-EPMC7691501 | biostudies-literature
UnknownComparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
Not available
S-EPMC4378855 | biostudies-literature
UnknownIn-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor.
Not available
S-EPMC9983862 | biostudies-literature
UnknownRandomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial.
Not available
S-EPMC9617573 | biostudies-literature
UnknownExome sequencing of 457 autism families recruited online provides evidence for autism risk genes.
Not available
S-EPMC6707204 | biostudies-literature
Sort   by:  
 Page size